Diagnostics & biomarkers

Down Syndrome Cannot Stay Outside Alzheimer’s Trials

A Blood Test Will Not Fix Colorectal Screening by Itself

Tau Is Back. Certainty Is Not.

Gonorrhoea Is Learning To Beat Ceftriaxone. Europe Must Move First.

Why some “resistant” hypertension isn’t resistant at all, and what cardiology might be missing

When Dementia Takes Speech, Trials Must Catch Up

Ultra-processed food may leave a metabolic fingerprint in the blood.

New global heart failure definition exposes a policy gap: systems still diagnose too late and treat too narrowly

Early Lung Cancer Just Became a Biomarker Test of the System
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
